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SUMMARY 
 Shrimp farming plays a key role in economy of many countries all over the world. Unfortunately, a disease 
called Acute Hepatopancreatic Necrosis Disease (AHPND) or Early Mortality Syndrome (EMS) caused by 
Vibrio parahaemolyticus spreading from Asia to Central America costs shrimp industry billions of dollars 
annually. In the past few years, scientists from multi-disciplinary field collaborated to find out a solution for 
this disease. Until now, there are not any effective approaches to prevent and cure this disease. However, co-
culturing shrimp with tilapia was carried out to limit the outbreak of AHPND in farm scale in many countries. 
Some previous studies also mentioned the benefits of this farming method to prevent other pathogens. The aim 
of this research is to determine whether intrinsic factors or cultured water of tilapia play role in inhibition of V. 
parahaemolyticus – pathogen causing AHPND. These factors include: mucus on tilapia gill and skin, tilapia 
fecal material, and microbiota or dissolved chemicals in culturing of tilapia. Anti-V. parahaemolyticus activity 
of tilapia (Oreochromis niloticus) fresh and overnight incubated feces and mucus were tested using agar well 
diffusion method. The effectiveness of feces and mucus inhibition was not clear, both of samples generated a 
weak inhibition on V. parahaemolyticus. Determination of V. parahaemolyticus inhibiting factor of tilapia 
cultured water using challenge test showed that dissolved compounds (smaller than 0.22 µm) inhibited the 
growth of V. parahaemolyticus. The presence of these compounds in tilapia-cultured water reduced V. 
parahaemolyticus to 17 times lower than that of the negative control with the seawater alone within the first 
three hours post challenge.  
Keywords: AHPND, EMS, mucus on tilapia gill and skin, shrimp, tilapia feces, tilapia water, V. 
parahaemolyticus 
INTRODUCTION 
 Shrimp is one of the high-value commodities 
and Pacific white shrimp (Panaeus vannamei) is the 
main species cultured in most of the coastal 
countries in Asia such as Thailand, China, Vietnam, 
Malaysia, Philippines. Over the past five years, the 
world shrimp industry has suffered devastating 
losses due to acute hepatopancreatic necrosis disease 
(AHPND), which was also known as early mortality 
syndrome (EMS). AHPND caused a loss of 5.8 
percent (to 3.25 million metric tons (MMT)) in 2012 
and 1.1 percent (to 3.21 MMT) in 2013 to the world 
shrimp production (Anderson et al., 2016). The loss 
was especially severe in the Asian region (FAO, 
2013). Recent study indicates that a particular strain 
of V. parahaemolyticus can causes mass mortality 
with typical AHPND histopathology including 
severe atrophy of the shrimp hepatopancreas, 
massive sloughing of hepatopancreatic epithelial 
cells into tubule lumens during first 30 days after 
stocking (Tran et al., 2013). Tubule cell death is 
caused by the binary toxin Photorhabdus insect-
related (PirAvp/PirBvp) encoded in the AHPND – 
associated plasmid of the bacterial V. 
parahaemolyticus cells (Lee et al., 2015). 
 Measures to control disease spread have been 
implemented in a number of shrimp farms, including 
improvement of farm and shrimp health management 
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practices, or the application of probiotics, traditional 
herbal medicine and molasses. However, the 
effectiveness of these measures has not been 
evaluated (FAO, 2013). 
 Meanwhile, some studies report that tilapia-
shrimp polyculture increases the shrimp production 
and profits which is higher than in monoculture 
(Hernández-Barraza et al., 2012; Yuan et al., 2010). 
Farming tilapia and shrimp together, also improves 
cultured water quality, ecological stability and 
function of shrimp monoculture (Yuan et al., 2010). 
According to Yi and Fitzsimmons (2004), tilapia 
improve the water color stability and reduce the 
proportion of shrimps infected by AHPND bacteria 
when using tilapia-shrimp polyculture. Tendencia et 
al., (2004) noted that the presence of tilapia in the 
water can directly inhibit the growth of Vibrio 
harveyi (a species in the same Harveyi clade of V. 
parahaemolyticus). The authors also suggested that 
fish-associated microflora may present anti-Vibrio 
activity. It was reported that the gut and feces of 
tilapia abound with useful fungi e.g., Penicillium and 
Aspergillus and yeasts, which could work against the 
proliferation of luminous bacteria V. harveyi (Leaño 
et al., 2005). Similarly, Lio-Po et al., (2005) reported 
that the ability of the “green water” to prevent the 
outbreaks of luminous vibriosis in the tiger shrimp 
grow-out ponds could be attributed to the presence 
of anti-Vibrio factors in micro-biota in the water, and 
on the skin mucus of tilapia. In addition, Tran et al., 
(2014) reported that using tilapia in the reservoirs of 
shrimp farms prior to stocking shrimp could induce 
healthy, balanced biota communities in the pond 
water, which could give beneficial effects to 
AHPND prevention. Tilapia is known as a 
biomanipulator, produce substances that can 
suppress myriad of pathogen, including Vibrios 
(Cruz et al., 2008). However, the mechanism behind 
these phenomena remains to be clarified.  
 Our study aimed to identify potential factors 
associated with the tilapia itself or the culturing of 
tilapia, which inhibit the growth of V. 
parahaemolyticus. Particularly, the study 
investigated the anti-Vibrio activity of fecal 
materials and mucus isolated from the skin and gills 
of the tilapia, Oreochromis niloticus. Furthermore, 
V. parahaemolyticus inhibition activity of algae, 
bacteria and dissolved chemical compounds in 
tilapia cultured water was also evaluated. The results 
of this study could be used as a reference for 
developing a model of using tilapia to control the 
outbreak of AHPND, reducing the loss caused by 
this disease to the shrimp farming.  
MATERIALS AND METHODS 
Preparation of tilapia feces, mucus and cultured 
water 
 This study was conducted in laboratories of 
International University (IU). Seawater 
(approximately 500 L) with the salinity of 30 ppt 
used for experiment was transported from Can Gio 
beach to Aqualab (IU). Tilapia, which were healthy, 
not injured, and similar in size (30 g/individual), 
provided by University of Agriculture and Forestry 
were used for the experiments. 
 Seawater was diluted to 15 ppt in 500 L (1.5 x 
0.5 x 0.7 m) composite tank before stocking of the 
tilapia at the density of 20 tilapia/m3 of water. All 
tilapia were transferred and stocked in cultured tank 
with aeration system for two weeks before 
experiment. Commercial fish feed of Uni-president 
company with 36% crude protein (pellet diameter 
between 2 and 2.5 mm) was provided for tilapia 
daily at amount equivalent to 1.5% of body weight. 
 The fragment of the fish intestine containing 
feces, which was the darker part of the intestine, was 
collected from two fishes, pooled and homogenized 
to be used as the fecal material for subsequent 
experiments. Fecal material was then divided into 
two portions. One portion was used immediately for 
the agar well diffusion test and the other was 
incubated at 30oC for 24h to imitate the possible 
proliferation of beneficial bacteria at the bottom of 
pond in the field before being used in the 
experiment. The former was referred as the fresh 
fecal material and the later as the enriched fecal 
material.  
 Mucus layer on the skin and gill from 2 fishes 
were scraped slightly by sterile knife, transferred to 
clean 1.5 ml Eppendorf tubes, and stored on iced 
until used. 
Bacterial strains and media 
 V. parahaemolyticus was provided by the Research 
Institute for Aquaculture No. 2 (RIA2) and stored at -
80oC in tryptone soybean broth (TSB) (HiMedia, India) 
with 2% NaCl with 15% glycerol. Bacterial strain was 
cultured in TSB with 2% NaCl and maintained on agar 
plates. Thiosulfate-citrate-bile salts-sucrose (TCBS) 
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agar (HiMedia, India) for selecting Vibrio strains was 
used for well diffusion test. 
Confirmation of AHPND related strain by 
multiplex PCR 
 DNA was extracted from the V. 
parahaemolyticus stock that was going to be used in 
the challenge tests using AccuLite AHPND 
Detection Kit (EMS) of Khoa Thuong 
Biotechnology Company. The isolated DNA was 
then used as template for multiplex PCR to confirm 
pathogenic strain causing AHPND as instruction 
from the kit producer. 
 Seawater used for challenges tests was also 
checked for the presence of V. parahaemolyticus by 
multiplex PCR.  
Agar well diffusion assay to test antibacterial 
activity of tilapia feces and mucus on V. 
parahaemolyticus 
 V. parahaemolyticus was inoculated in 50 ml 
TSB with 2% NaCl, and then incubated at 37⁰C in a 
rotary shaker agitated at 90 rpm overnight. The 
density of inoculum was checked by measuring the 
turbidity of the suspension at OD600. The bacterial 
suspension was then diluted to 106 CFU/ml with 
0.9% NaCl solution. After that, 200 µl of diluted 
bacterial suspension was transferred on to each of 
TCBS plates and spread using triangle loop until dry 
completely. On each plate, four wells with diameter 
of 6 mm were then made. Fresh or enriched fecal 
sample or mucus was put into two wells (3 g/well for 
feces and 2 g/well for mucus). Other two wells were 
filled with 50 µl distilled water or 50 µl of 0.1 mg/ml 
doxycycline (STADA, Vietnam) as negative and 
positive control, respectively. These plates were 
incubated for 24-48 hours at 30oC. The presence of 
antibacterial zone of inhibition was checked after 
incubation. The experiment was performed in 
triplicate. 
Challenge tests to identify factor(s) (i.e. algae, 
bacteria or dissolved compounds) in tilapia 
cultured water that could inhibit the growth of V. 
parahaemolyticus  
 This experiment was conducted in 12 PVC 
cylinders (d x h = 500 x 90 mm) to simulate the 
depth of the water column in the actual shrimp 
ponds. Each cylinder was aerated by aeration system. 
The cylinders were divided into four groups of three 
cylinders each. Each group was correspondent to one 
treatment. In other word, the experiment was set up 
with four treatments, which was run in triplicate. 
Each cylinder of NF group contained 2.5 L tilapia 
cultured water, which was not filtered before being 
added into the cylinders. Each cylinder of NA group 
contained 2.5 L tilapia cultured water which was 
filtered with ashless filter paper, Grade 589/3, 2 µm 
(Whatman, German) to remove algae. NAB 
treatment contained 2.5 L tilapia cultured water 
which was filtered with the nylon filter membrane 
0.22 µm (Finetech, Taiwan) to remove both algae 
and bacteria from the water. Cylinders of SW group, 
which served as the negative control contained 2.5 L 
seawater, part of which was originally used for 
culturing of tilapia. Water in the SW group, 
therefore, shall have similar composition with the 
water used for the NF group except for the microbial 
community or dissolved chemical compounds that 
were created and/or produced by the culture of 
tilapia. Table 1 indicates differences between the 
four treatments in term of factors that were 
potentially involved in V. parahaemolyticus 
inhibiting activity of the tilapia culture water.  
Table 1. Source of water and anti – V. parahaemolyticus potential components in four treatments. NF – non – filtered tilapia 
cultured water; NA – tilapia cultured water removed algae; NAB – tilapia cultured water removed algae and bacteria; SW – 
sea water. 
Treatment Source of water 
Presence (+)/ Absence (-) of potential V. 
parahaemolyticus inhibition components 
Algae Bacteria Dissolved chemical 
compounds 
NF Non- filtered tilapia cultured water + + + 
NA Tilapia cultured water which was filtered through 2 µm filter membrane - + + 
NAB Tilapia cultured water which was filtered through 0.22 µm filter membrane - - + 
SW Sea water - - - 
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 Bacterial strain was inoculated in 500 ml TSB 
with 2% NaCl, and then incubated at 37⁰C in a 
rotary shaker agitated at 135 rpm for seven hours. 
After that, bacterial suspension was spread on TCBS 
agar plates for determination of V. parahaemolyticus 
density. All treatments were challenged with V. 
parahaemolyticus at the final density of 5x105 
CFU/ml.  
 According to unpublished data (Ho, 2016), the 
changing of V. parahaemolyticus concentration 
occurs within the first 24 hours post challenge. 
Therefore, sample collection time was scheduled to 
the following timepoints: 0 – 3 – 6 – 9 – 12 – 18 – 
24-hour post challenge. At each time point, five 
milliliters of water sample were collected from each 
cylinder.  
 Concentration of V. parahaemolyticus of each 
sample was then determined by plate-counting 
method using the TCBS agar plates. Samples were 
diluted with 0.9% NaCl in a 10-fold serial dilution; 
100 µl of diluted cell suspension was then spread on 
TCBS agar plate by a triangle loop. The plates were 
incubated at 37°C for 24h. Bluish green colonies that 
appeared on the plates were then counted. 
RESULTS 
Confirmation of AHPND causing V. 
parahaemolyticus strain by multiplex PCR 
 The V. parahaemolyticus stock provided by 
RIA2 was confirmed to be the AHPND causing 
strain by multiplex PCR (Fig. 1).  In the other hand, 
tilapia cultured water was confirmed to be free of 
AHPND causing V. parahaemolyticus strain. So, 
both tilapia cultured water and the bacteria were 
appropriate to be used in the challenge tests.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Confirmation of VPAHPND strain by multiplex PCR.  Lane L – ladder; Lane 1- Tilapia cultured water; Lane P - Positive 
control (333 bp); Lane N - Negative control; Lane V -  AHPND - causing V. parahaemolyticus used in the challenge test. 
	
Figure 2. Agar well diffusion to check antibacterial activity result on representative plates for each type of tested sample. A 
– fresh feces; B – enriched feces; C – mucus. 
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Testing antibacterial activity of tilapia fecal 
materials and mucus using agar well diffusion 
assay 
 Antibacterial activity of tilapia fecal materials 
and mucus testing using well diffusion method is 
shown in figure 2. There were no completely 
clearing zone observed around wells containing the 
fecal or mucus materials. However, bacterial 
colonies adjacent to these wells were smaller than 
those further from the wells and they were in less 
number as well, thus creating the pseudo transparent 
rings around the wells containing either feces or 
mucus sample as shown in figure 2. These results 
show that fresh, enriched feces and mucus have a 
weak growth inhibition effect on V. 
parahaemolyticus.  
Factors in tilapia cultured water inhibit V. 
parahaemolyticus 
 Water parameter including pH, temperature, 
salinity in all cylinders used for the challenge tests 
were measured just before V. parahaemolyticus was 
added to make sure that environmental factors would 
not be the variable(s) that would influence the test 
outcome. Indeed, it was found that these parameters 
were of approximately equal among different 
treatment, pH and temperature was in range of 
optimized conditions for growth of V. 
parahaemolyticus (pH: 7 – 8, temperature: 24 – 30). 
Therefore, the differences in V. parahaemolyticus 
density among treatments, if there were, were not 
accounted by these environmental factors.  
 Figure 3 shows the temporal changes in bacterial 
number in the four treatments. It can be seen that the 
number of bacteria at the initial time point (just after 
the addition of was V. parahaemolyticus into the 
cylinders or 0-hour post challenge) was 
approximately equal to 5x105 CFU/ml and 
insignificantly different between treatments Bacterial 
density in the SW treatment increased during the 
first three hours post challenge (p < 0.05), but then 
reduced to the level insignificantly different from the 
initial concentration at the 0- hour time point (p > 
0.05) until the end of the experimental period 
Bacterial densities in the NF, NA and NAB 
treatments, which containing filter or non-filtered 
tilapia culture water (Table 1), at three-hours post 
challenge were all significantly lower (p < 0.05) than 
that of the negative SW treatment (approximately 17 
times lower, Figure 3) Within each treatment, the 
bacterial densities in NF, NA and NAB at three-
hours post challenge significantly drop compared 
with the number of bacteria at the 0-hour time point 
(p < 0.05) (Figure 3). From three to 24 hours, the 
total number of sucrose non-fermenting Vibrio spp.  
remained low and had no significant temporal 
change in these treatments (Figure 3). This result 
indicates that efficiency of V. parahaemolyticus 
inhibition activity of tilapia water is not different 
among the NF, NA and NAB treatments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Temporal changes in total number of sucrose non-fermenting Vibrio spp. in bacterial challenge test with V. 
parahaemolyticus. Bacterial densities are expressed as mean ± SD (CFU/ml). NF – non – filtered tilapia cultured water; NA – 
tilapia cultured water removed algae; NAB – tilapia cultured water removed algae and bacteria; SW – sea water.  
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 The SW treatment showed higher bacterial 
concentration than the other treatments during the 
period between six to 24 hours. The differences 
were, however, not significant. 
DISCUSSION 
 AHPND is a serious global disease, causing the 
loss of billions dollar to the shrimp production 
annually, and thus, is urgently required effective 
controlling methods. A deeper understanding of how 
co-culturing tilapia could lead to the reduction in 
damage caused by AHPND would help us actively 
plan strategies to control this disease.  
 Using agar well diffusion method to determine 
antibacterial activity of fecal material and mucus 
collected from tilapia showed that both materials 
could weakly inhibit the growth of V. 
parahaemolyticus, AHPND causing agent (Figure 2). 
This result is not in line with those of studies on 
antimicrobial effect of tilapia feces and mucus on the 
luminous bacteria V. harveyi. (Tendencia, dela Peña, 
2003) reported that the tilapia (Tilapia hornorum) 
culture water, which were depleted of algae by 
culturing fish in the dark, well inhibited the growth 
of V. harveyi over a period of up to six days post 
challenge. It was proposed that bacteria of the gut 
flora of the fish, which are excreted into the water 
together with the feces, accounted for this repressive 
effect on luminous bacteria. In another study, the 
aqueous skin extracts of high saline and freshwater 
tilapia, Oreochromis mossambicus and Oreochromis 
sp. GIFT strain, could also inhibit the growth of V. 
harveyi (Caipang et al., 2011). In the study of 
Wibowo et al., (2015), tilapia mucus proteins were 
separated using Bradford method. These extracted 
proteins, with known concentration, were then used 
to test antibacterial effect against V. harveyi. In our 
study, mucus from tilapia skin and gill were scraped 
and directly used in the antimicrobial tests instead. 
The lack of strong antimicrobial activity of the 
mucus in our experiment may, therefore, due to the 
low concentration of potential antibacterial 
compounds existed in each well on the plate. The 
weak inhibition activity against V. parahaemolyticus 
of O. niloticus feces and mucus as demonstrated by 
the agar well diffusion method in our study suggests 
that they are not the main factors account for the 
observed AHPND controlling effect when shrimp 
was co-cultured with the tilapia. 
 On the contrary, results of the challenge tests 
strongly indicate that tilapia culture water contained 
component(s) that could efficiently inhibit the 
growth of V. parahaemolyticus (Figure 3). These 
results are consistent with previous study by Tran et 
al., (2014), who reported that water collected from 
the culturing of the tilapia O. niloticus could reduce 
shrimp mortality in the challenge test, in which 
Litopaneus vannamei was challenged with 3x105 
cells/ml AHPND causing strain of V. 
parahaemolyticus. Tran et al. (2014), however, did 
not provide data showing the change of V. 
parahaemolyticus count at the end of the challenge 
test. In our experiment, the bacterial densities in 
treatments, in which filtered and non-filtered tilapia 
culture water were used (the NF, NA and NAB 
treatments), significantly reduced (at least four 
times reduction from 0-hour time point) during the 
first three hours post challenge and significantly 
lower than those of the negative control, in which 
tilapia culture water was replaced by the sea water. 
From nine hours post challenge, bacterial count in 
each of these treatments then stayed as low as 
4x103 CFU/ml until the end of the experiment (24 
hours post challenge). It should be noted that 104 
CFU/ml was considered as the threshold V. 
parahaemolyticus density, below which no shrimp 
mortality was observed in the study of Soto-
Rodriguez et al., (2015). 
 Our result indicated that factor that directly 
influenced the growth of V. parahaemolyticus is not 
algae, which were filtered out of tilapia culture water 
used in NA treatment, and bacteria, which were not 
present in the water used in NAB treatment. Soluble 
compounds that could passed through the 0.22 µm 
filter membrane, on the other hand, existed in water 
used for the NF, NA and NAB treatments, and thus, 
should be factor that exerted the direct inhibition 
activity against the growth of V. parahaemolyticus. 
Some previous studies from other authors support 
this finding. Makridis et al., (2006) suspected that 
superoxide produced by Chlorella and Tetraselmis, 
the two algae that often found the green water, may 
inhibit Vibrio growth. Moreover, some researchers 
showed that active substances from marine bacteria 
like Pseudomonas sp., Pseudoalteromonas sp. also 
have anti-Vibrio activity (Aranda et al., 2012; 
Rattanachuay et al., 2010). Therefore, further 
investigation into the characteristics and origins of 
these useful chemical compounds is necessary.  
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Conclusion and recommendation 
 In conclusion, this study found that (1) tilapia 
fecal materials and mucus have very weak 
antibacterial activity; (2) soluble compounds smaller 
than 0.22 µm in tilapia cultured water could directly 
and effectively inhibit the proliferation of V. 
parahaemolyticus. Their effect appeared rapidly, 
significant drop in V. parahaemolyticus density was 
readily observed in the first three hours post 
challenge.  
 Our finding would contribute to the development 
of effective strategies to protect the shrimp industry 
from the loss caused by AHPND. However, further 
studies are necessary to identify the nature and origin 
of antimicrobial compounds existing in tilapia 
cultured water. Assays like TLC, GCMS, FTIR will 
help us to narrow down the groups of bioactive 
compounds that have antimicrobial activity against 
V. parahaemolyticus. This information could serve 
as guidance for subsequent identification of the 
microorganisms that are the producers of these 
compounds. 
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KHẢ NĂNG ỨC CHẾ VI KHUẨN GÂY BỆNH HOẠI TỬ GAN TỤY CẤP (AHPND) - 
VIBRIO PARAHAEMOLYTICUS - CỦA PHÂN, CHẤT NHẦY VÀ NƯỚC NUÔI CÁ RÔ 
PHI - OREOCHROMIS NILOTICUS 
 
Lê Ngọc Phương Thanh, Hồ Hải Cơ, Trịnh Thị Trúc Ly, Hoàng Tùng, Bùi Thị Hồng Hạnh 
Đại học Quốc tế, Đại học Quốc gia Thành phố Hồ Chí Minh 
TÓM TẮT 
 Nuôi tôm đóng vai quan trọng trong nền kinh tế của nhiều nước trên thế giới. Nhưng trong những năm gần 
đây, bệnh hoại tử gan tụy cấp (AHPND), còn được biết đến như “Hội chứng chết sớm ở tôm” (EMS), đã gây 
thiệt hại lên đến hàng tỷ đô la cho nghề nuôi tôm ở các quốc gia khu vực châu Á và Trung Mỹ. Cho đến nay, 
chưa có giải pháp hữu hiệu để ngăn ngừa và điều trị AHPND. Tuy nhiên, nhiều trang trại nuôi tôm ở một số 
nước đã ghi nhận nuôi ghép tôm và cá rô phi có thể hạn chế sự xuất hiện và bùng phát của AHPND. Mục tiêu 
của nghiên cứu này là xác định các yếu tố nội sinh của cá rô phi hoặc nước nuôi cá có khả năng gây ức chế sự 
phát triển của Vibrio parahaemolyticus – tác nhân gây AHPND. Các yếu tố được khảo sát bao gồm: chất nhầy 
trên da cá, mang cá, phân cá, và các thành phần vi sinh hoặc chất hoà tan trong nước nuôi cá. Khả năng ức chế 
V. parahaemolyticus của phân cá lấy trực tiếp hoặc ủ qua đêm và chất nhầy trên da và mang cá được kiểm tra 
bằng phương pháp khuếch tán qua giếng thạch. Cả hai loại phân cá và chất nhầy đều cho kết quả ức chế yếu. 
Thử nghiệm sàng lọc tác nhân ức chế V. parahaemolyticus trong nước nuôi cá bằng phương pháp cảm nhiễm 
cho thấy các hợp chất hòa tan có kích thước nhỏ hơn 0.22 µm có khả năng ức chế sự phát triển của V. 
parahaemoliticuscao gấp 17 lần so với nghiệm thức đối chứng âm trong khoảng ba giờ đầu tiên sau cảm 
nhiễm. 
Từ khóa: AHPND, chất nhầy trên da và mang cá rô phi, EMS, nước nuôi cá rô phi, phân cá rô phi, tôm, 
Vibrio parahaemolyticus 
 
